MEDXF   $2.24  1.82% Market Closed

MEDEXUS PHARMS INC
Total Cash 8.45M
totalCashPerShare 0.345
EBITDA 17.86M
Total Debt 46.84M
quickRatio 0.366
currentRatio 1.105
Total Revenue 108.78M
debtToEquity 143.723
Revenue/Share 4.653
ROA 0.048850004
ROE 0.03948
grossProfits
freeCashflow 13.51M
operatingCashflow 22.69M
earningsGrowth 1.67
revenueGrowth -0.135
grossMargins 0.57573
ebitdaMargins 0.16416
operatingMargins 0.15871
profitMargins 0.010039999
enterpriseValue 81.30M
forwardPE 31.6
floatShares 22.18M
sharesOutstanding 24.53M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.09%
heldPercentInstitutions 0.08%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 1.332
Price To Book help_outline 1.19
earningsQuarterlyGrowth 2.01
netIncomeToCommon 1.09M
trailingEps 0.04%
forwardEps 0.05%
enterpriseToEbitda 4.55
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.01 3Q 2024
institutionsCount 4
lastUpdated Nov. 7, 2024, 3:23 a.m.